Patients who received an implantable heart defibrillator in everyday practice had survival benefits on par with those who received the same devices in carefully controlled clinical trials, according to a new study that highlights the value of...
Join Scoop.it for Free
Share ideas that matter on the social web and experience
the benefits of curating the world's best content.
I don't have a Facebook, a Twitter or a LinkedIn account
Already have an account: Login
Keeping the eye on ever changing dynamics of two apparently distinct but interconnected realms of healthcare and business.
Curated by
Usman Sattar
|
Scooped by Usman Sattar onto Realms of Healthcare and Business |
Scoop.it!
No comment yet.
Sign up to comment
Delete the scoop?
Are you sure you want to delete this scoop?
Yes
 Your new post is loading...
Scoop.it!
Survey of physicians from around the country attempting to explain why there is a decrease in PCI (angioplasty) volumes. The different explanations and regional variation is fascinating. My views are similar to the New England practioner surveyed. In Massachusets we have the lowest level of uninsured patients in the nation so the economuc factors here are less likely a contributor. Has a hopeful optimist and enthusiast for prevention strategies I favor stain use as the #1 cause. I think the COURAGE trial had no impact at all. Via Seth Bilazarian, MD Delete the scoop?
Are you sure you want to delete this scoop?
Yes
|
